Human papillomavirus type 16 (HPV-16) is strongly associated with the development of cervical carcinoma (Gissmann et al., 1984) , and although cooperation between the virus-encoded E6 and E7 proteins is necessary for full immortalization of primary human keratinocytes (Hawley-Nelson et al., 1989; Miinger et al., 1989) , E7 is the principal oncoprotein in rodent cells, in which it can transform primary cells in cooperation with ras (Crook et al., 1988; Phelps et al., 1988) . E7 is able to form a complex with the retinoblastoma gene product (RB) (Dyson et al., 1989) , and it seems likely that this interaction disrupts the normal function of RB in negatively regulating cell division. E7 is also phosphorylated on two adjacent serine residues by casein kinase II (Firzlaff et al., 1989) . Although RB binding and phosphorylation appear to be independent functions of E7, both are necessary for full transforming activity (Barbosa et al., 1990) . Another activity of E7, which maps to the N terminus of the protein, can be separated from RB binding (Watanabe et al., 1990; Banks et al., 1990) . This function, which is uncharacterized, is also necessary for efficient transforming activity.
E7 shows both functional and structural similarity to adenovirus E1A and simian virus 40 large T antigen (LT) (Phelps et al., 1988) . Like E7, these proteins can cooperate with ras to transform primary rodent cells and are able to form a complex with RB (DeCaprio et al., 1988; Whyte et al., 1988) . The region of sequence similarity between the three proteins corresponds to E 1A conserved region 2 (CR2) and in each case these sequences play an important role in RB binding (Barbosa et al., 1990; DeCaprio et al., 1988; Egan et al., 1988; Whyte et al., 1989) . RB binding by LT has been shown to substitute for that of E1A in both a chimeric protein (Moran, 1988) and when introduced on a separate molecule . We investigated whether RB binding by E7 can also substitute in trans for RB binding by E1A.
The ability to bind RB is necessary but not sufficient for the full transforming activity of any of these oncoproteins, and EIA and LT interact with a number of other cell proteins which may also play an important role in transformation (Ewen et al., 1989; Harlow et al., 1986; Lane & Crawford, 1979; Yee & Branton, 1985) . Although the binding of many of these cell proteins involves a region of E1A similar to that which participates in RB binding, binding of one of the E1A-associated proteins, p300, requires sequences at the N terminus of E1A, including CR1, distinct from those necessary for RB binding (Egan et al., 1988; Stein et al., 1990; Whyte et al., 1989) . Certain activities of E 1 A, such as the transcriptional regulation of some cellular genes (van Dam et al., 1989 ) and complementation of a growth defect in a conditionally immortalized cell line (Riley et al., 1990 ) have been linked with p300 binding. This indicates that for some functions the association of E 1A with p300 is more important than that with RB. The function of p300 is unclear, but the protein appears to play a role in the control of cell division (Egan et al., 1988; Jelsma et aL, 1988; Whyte et aL, 1989) . Since p300 and RB binding are independent activities, transformation-defective E1A mutants which encode proteins deficient for one or other activity can cooperate in trans to transform primary rodent cells (Moran & Zerler, 1988) . It has also recently been shown that LT can provide an activity complementary to that of p300 binding by EIA . Interestingly, the N teminus of E7 shows some similarity with E1A CR1 (Phelps et al., 1988) , and because an N-terminal mutant of E7 loses transforming activity despite retaining the ability to bind RB (Watanabe et al., 1990; Banks et al., 1990) , we attempted to assess whether E7 can also complement such a p300-binding activity via this region. Experiments were undertaken using a series of transformation-defective E7 and E1A mutants (Fig. 1) . The E1A protein encoded by GCX (Schneider et al., 1987) , and E7 proteins encoded by p24GLY and p26GLY (Edmonds & Vousden, 1989) have been shown to be unable to bind RB (Barbosa et al., 1990; Riley et al., 1990) , whereas pm563 (Whyte et al., 1989) encodes an E1A N-terminal mutant protein which does not bind p300. p2PRO encodes an E7 protein with an N-terminal mutation which is also transformation-defective, despite retaining the ability to bind RB; the functional defect in this protein is unknown (Banks et al., 1990) . Primary baby rat kidney cells (BRKs) were transfected with various combinations of E 1A and E7 mutants and EJ-ras (pEJ6.6) (Shih & Weinberg, 1982) using calcium phosphate coprecipitation (Crook et al., 1988) . pSV2Neo was included to allow the selection of transformed colonies using G418 (Southern & Berg, 1982) . As positive controls for transformation, HPV-16 E7 (pMoE7) (Edmonds & Vousden, 1989) or E1A (pCE) (Schneider et al., 1987) plasmids were used in conjunction with ras (Table  1) . Each of the mutants individually was largely transformation-defective. The independence of the RBbinding and the N-terminal activities of E1A is demonstrated in the combination GCX and pm563, which is slightly less efficient in transformation than E 1A itself. Although GCX and p2PRO individually are almost completely transformation-defective, the plasmids can cooperate readily to transform BRKs in conjunction with ras (Table 1) . Complementation between these mutants is as efficient as that between E1A mutants. Expression of the transfected plasmids was confirmed by immunoprecipitation of E 1A and E7 proteins from independently isolated colonies of cells arising after transfection, as described previously (Edmonds & Vousden, 1989) . Briefly 2 x l06 cells were labelled for 2 h with 0.5 mCi [35S]cysteine. Cell extracts containing approximately 5 x l0 T c.p.m, were used for each immunoprecipitation, and proteins were precipitated with monoclonal antibody M73, specific for E1A (Harlow et al., 1985) , or a polyclonal rabbit anti-HPV-|6 E7 antibody (Barbosa et al., 1990) , and then resolved by SDS-PAGE (Fig. 2) . The independently isolated cell lines tested all showed the presence of both proteins, implying that the complementation between GCX and p2PRO occurs at the protein level. Thus RB binding by E7 can, like that of LT , substitute for RB binding by E1A. This provides further evidence that the RB-binding activity is present as a self-contained domain shared between E7, E1A and LT.
Although both pm563 and p2PRO can efficiently complement the non-RB-binding E1A mutant GCX, pm563 and p2PRO were unable to complement each other. This indicates that the activity lost from the E1A The difference in the migration of the wild-type and p2PRO E7 proteins can be seen.
protein encoded by pm563 is not available in the E7 protein encoded by p2PRO, and therefore suggests that the defect within each of these two mutants is functionally equivalent. Since the E1A mutant pm563 is unable to bind p300, it is possible that the E7 mutant p2PRO has also lost this or an equivalent activity. Interestingly, the two RB-binding-defective E7 mutants tested in this study (p24GLY and p26GLY) also failed to complement p2PRO. This lack of homogenic complementation strongly suggests that the mutations within E7 which destroy RB binding also affect other functions of the 1 2 3 4 5 6 7 p300--~ Fig. 3 . Immunoprecipitation of p300 protein by direct precipitation with an anti-p300 antibody (lanes 2, 5 and 7) or coprecipitation with E1A-or (lane l) E7-specific (lanes 3, 4 and 6) antibodies. The antibodies were used to precipitate proteins from cysteine-labelled extracts made from E1A-(293 cells, lanes 1 to 3) or E7-expressing (CaSki cells, lanes 4 and 5; SiHa cells, lanes 6 and 7) cell lines.
protein, including that lost in p2PRO. This hypothesis was supported further by the observation that p24GLY and p26GLY were also unable to complement the nonp300-binding E1A mutant pm563. Although both p24GLY and p26GLY were unable to function in all the rodent cell assays tested, the ability of these mutant E7 proteins to participate in the immortalization of primary human cells (Jewers et aL, 1992) clearly indicates that these single amino acid substitutions do not result simply in the general destabilization and complete loss of function of the E7 protein. However these mutations may result in disruption of the N-terminal function of E7 and it is possible that more conservative changes to the protein (e.g. Glu to Asp at position 26) might reduce RB binding but maintain other functions, allowing complementation with N-terminal E7 or E1A mutants. Our results suggest that the N-terminal function of E7 is dependent on the integrity of the RB-binding activity of the protein. The small size o r E 7 may limit the activity of the molecule, not permitting each function to occur autonomously, although functional RB binding clearly can occur without an active N-terminal function. Alternatively the N-terminal activity may be preceded by RB binding such that it can only function when RB is bound. The transforming activity of E1A is dependent on the ability to form a complex with both p300 and RB, indicating the importance of interference with the wildtype activity of both of these cell proteins. Therefore we examined two cervical carcinoma cell lines expressing HPV-16 E7 for evidence of either loss of p300 expression or complex formation between E7 and p300. These studies were carried out using SiHa and CaSki cells, both HPV-16-containing cervical carcinoma cell lines ex-pressing E7 protein (Smotkin & Wettstein, 1987) , and adenovirus-transformed 293 cells (Graham et al., 1977) . Immunoprecipitation of p300 and coprecipitations with E1A or E7 were carried out as described previously . Immunoprecipitations using an anti-p300 polyclonal rabbit antiserum (Fig. 3) indicated that 293, CaSki and SiHa cells all express p300 protein. The association between E 1A and p300 is clearly seen by coprecipitation of p300 by E1A in 293 cells, but we were unable to detect a similar coprecipitation of p300 with E7 in CaSki or SiHa cells using either the polyclonal antibody or a polyclonal antibody raised in rabbits against full-length E7 protein, kindly supplied by P. Beverly (Fig. 3) . Clearly we are unable to interpret our failure to detect an E7-p300 complex as evidence that such a complex does not exist because our results may simply reflect insufficient sensitivity or an inability of our antibodies to recognize such a complex. The detection of p300 protein in CaSki and SiHa cells indicates that they have not compensated for an inability of E7 to disrupt wild-type p300 function by complete loss of expression of this cell protein, although the p300 proteins detected in SiHa cells reproducibly resolved as a doublet, possibly reflecting an abnormality in the expression of this protein.
There is some evidence that E7 does encode an activity analogous to p300 binding by E1A. Rescue of a conditionally immortalized rat embryo fibroblast line requires only the p300-binding function of E1A, RB binding appearing to play no role in this particular activity of the E1A protein (Riley et al., 1990) . Since E7 has been shown to function in this assay (Vousden &Jat, 1989) , it seems likely that E7 can either bind p300 or provide another function important for this activity. Interestingly, the non-RB-binding E7 mutants lose the ability to complement the growth defect in these cells (Chesters et al., 1990) , supporting the notion that this region of E7 is necessary for functions additional to RB binding.
